Free Trial

Koninklijke Philips (NYSE:PHG) Upgraded at StockNews.com

Koninklijke Philips logo with Medical background

Koninklijke Philips (NYSE:PHG - Get Free Report) was upgraded by StockNews.com from a "hold" rating to a "buy" rating in a report issued on Thursday.

PHG has been the subject of several other research reports. UBS Group raised Koninklijke Philips from a "neutral" rating to a "buy" rating in a research note on Thursday. Jefferies Financial Group upgraded shares of Koninklijke Philips from an "underperform" rating to a "hold" rating in a research note on Tuesday, October 29th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy".

Read Our Latest Analysis on PHG

Koninklijke Philips Trading Up 1.8 %

Shares of NYSE PHG traded up $0.46 during midday trading on Thursday, reaching $26.01. The stock had a trading volume of 1,798,006 shares, compared to its average volume of 729,409. The company's 50 day moving average price is $26.25 and its 200 day moving average price is $28.13. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.74 and a current ratio of 1.23. Koninklijke Philips has a twelve month low of $19.75 and a twelve month high of $32.91. The firm has a market cap of $24.44 billion, a price-to-earnings ratio of -30.96, a price-to-earnings-growth ratio of 0.82 and a beta of 0.77.

Koninklijke Philips (NYSE:PHG - Get Free Report) last released its earnings results on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.01). Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. The firm had revenue of $5.38 billion during the quarter, compared to analyst estimates of $5.10 billion. As a group, sell-side analysts expect that Koninklijke Philips will post 1.63 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Forum Financial Management LP raised its stake in shares of Koninklijke Philips by 18.0% in the fourth quarter. Forum Financial Management LP now owns 11,703 shares of the technology company's stock worth $296,000 after purchasing an additional 1,784 shares during the last quarter. Castlekeep Investment Advisors LLC purchased a new stake in Koninklijke Philips in the 4th quarter valued at $114,000. Vise Technologies Inc. lifted its stake in Koninklijke Philips by 50.9% during the 4th quarter. Vise Technologies Inc. now owns 14,224 shares of the technology company's stock valued at $360,000 after acquiring an additional 4,795 shares in the last quarter. Vident Advisory LLC boosted its holdings in Koninklijke Philips by 6.4% during the 4th quarter. Vident Advisory LLC now owns 36,788 shares of the technology company's stock worth $932,000 after acquiring an additional 2,210 shares during the last quarter. Finally, Strive Asset Management LLC bought a new stake in shares of Koninklijke Philips in the 4th quarter worth $401,000. Institutional investors own 13.67% of the company's stock.

Koninklijke Philips Company Profile

(Get Free Report)

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.

Further Reading

Analyst Recommendations for Koninklijke Philips (NYSE:PHG)

Should You Invest $1,000 in Koninklijke Philips Right Now?

Before you consider Koninklijke Philips, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.

While Koninklijke Philips currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Cashes In on Stocks—Here’s How You Can Too!
5 Stocks to BUY NOW in March 2025
Archer Aviation: Sinking Now, Soaring Soon?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines